Sunday, Jun 21, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Dr Reddys Q4 Profit Dips 28 To Rs 557 Cr

Dr Reddy’s Q4 profit dips 28% to Rs 557 cr

For FY21, the company posted a consolidated net profit of Rs 1,952 crore as against Rs 2,026 crore in 2019-20.

By Telangana Today
Published Date - 14 May 2021, 07:24 PM
Dr Reddy’s Q4 profit dips 28% to Rs 557 cr
whatsapp facebook twitter telegram

Hyderabad: Dr Reddy’s Laboratories reported 28 per cent decline in consolidated net profit at Rs 557 crore for the fourth quarter ended March 31, 2021, as against a net profit of Rs 781 crore in January-March quarter of 2019-20.

The company’s net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20, Dr Reddy’s Laboratories said.


For FY21, the company posted a consolidated net profit of Rs 1,952 crore as against Rs 2,026 crore in 2019-20. Net sales increased to Rs 18,420 crore during the last fiscal year as compared with Rs 16,357 crore in 2019-20.

“In FY 21, we continued to grow across all our businesses, enhance productivity and strengthen our development pipeline,” Dr Reddy’s Laboratories co-chairman and MD, G V Prasad said.

The company is prioritising its efforts to launch Sputnik V vaccine across India while working on the development and commercialisation of several drugs for the treatment of mild to severe Covid-19 infections, he added.

The company said it has commenced a detailed investigation into an anonymous complaint which alleges that healthcare professionals in Ukraine and potentially in other countries were provided with improper payments by or on behalf of the company in violation of US anti-corruption laws.

A legal firm is conducting the investigation at the instruction of a committee of the company’s board, it added. Dr Reddy’s noted that it has disclosed the matter to the US Department of Justice, Securities and Exchange Commission and Securities Exchange Board of India.

“While the matter may result in government enforcement actions against the company in the United States and/or foreign jurisdictions, which could lead to civil and criminal sanctions under relevant laws, the probability of such action and the outcome are not reasonably ascertainable at this time,” the company added.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Dr Reddy’s Laboratories
  • Dr.Reddy's

Related News

  • Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

    Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

  • Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

    Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

  • Dr Reddy’s Q3 profit dips 14 pc on weak US sales

    Dr Reddy’s Q3 profit dips 14 pc on weak US sales

  • Hyderabad-based Pharma Dr Reddy’s loses Rs 2.16 cr after fraudsters hack their email communication

    Hyderabad-based Pharma Dr Reddy’s loses Rs 2.16 cr after fraudsters hack their email communication

Latest News

  • Jalpaiguri bus accident: Four killed, 57 injured as NBSTC bus hits parked trailer on NH-27

    8 mins ago
  • India’s space economy may grow five-fold to USD 45 billion in a decade

    15 mins ago
  • Six killed in ammonia leak at Tiruvallur seafood unit, CM Vijay orders probe

    18 mins ago
  • ONGC expects natural gas output to grow 7-8 per cent annually

    19 mins ago
  • Hyderabad police review KBR Park traffic trial, permanent changes yet to be decided

    20 mins ago
  • Dharmendra Pradhan helps Bengal girl with broken ribs appear in NEET UG re-exam

    22 mins ago
  • Dipke continues Jantar Mantar sit-in, seeks farmers’ support for protest

    23 mins ago
  • Ram temple probe: SIT asks trust officials not to leave Ayodhya

    27 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam